Stereotactic radiation therapy, also called stereotactic external-beam radiation therapy and stereotaxic radiation therapy, is a type of external radiation therapy that uses special equipment to position the patient and precisely deliver radiation to a tumor. The total dose of radiation is divided into several smaller doses given over several days. Stereotactic radiation therapy is used to treat brain tumors and other brain disorders. It is also being studied in the treatment of other types of cancer, such as lung cancer. What differentiates Stereotactic from conventional radiotherapy is the precision with which it is delivered. There are multiple systems available, some of which use specially designed frames which physically attach to the patient's skull while newer more advanced techniques use thermoplastic masks and highly accurate imaging systems to locate the patient. The end result is the delivery of high doses of radiation with sub-millimetre accuracy
Based on the Stereotactic Body Radiation Therapy (SBRT) market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Stereotactic Body Radiation Therapy (SBRT) market covered in Chapter 5:
21st Century Oncology
Bionucleonics Inc.
Elekta AB
Bayer Healthcare Pharmaceuticals LLC
Cianna Medical
Brain Lab, Inc.
C-Rad AB
Accsys Technology Inc.
Eckert & Ziegler Bebig
Accuray Inc.
GE Healthcare
Carl Zeiss Meditech, Inc.
Filtrine
Dosisoft
C.R. Bard Inc
Bionix
Bxtaccelyon Limited
In Chapter 6, on the basis of types, the Stereotactic Body Radiation Therapy (SBRT) market from 2015 to 2025 is primarily split into:
External Radiation Therapy
Internal Radiation Therapy
Systemic Radiation Therapy
In Chapter 7, on the basis of applications, the Stereotactic Body Radiation Therapy (SBRT) market from 2015 to 2025 covers:
Prostate Cancer
Breast Cancer
Gynaecological Cancer
Gastrointestinal Cancer
Lung Cancer
Brain Cancer
Head & Neck Cancer
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Summary:
Get latest Market Research Reports on Stereotactic Body Radiation Therapy (SBRT). Industry analysis & Market Report on Stereotactic Body Radiation Therapy (SBRT) is a syndicated market report, published as Global Stereotactic Body Radiation Therapy (SBRT) Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Stereotactic Body Radiation Therapy (SBRT) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.